Corporate Events

Denka Company Limited has completed a Fixed-Income Offering in the amount of ¥10 billion. Security Name: 1.781% Notes due December 3, 2030 Security Type: Corporate Bond/Note (Non Convertible) Principal Amount: ¥10 billion Price\Range: 100% Coupon Type: Fixed

Denka Company Limited revised consolidated earnings guidance for first half of the fiscal year ending March 31, 2027. For the first half, the company expects net sales of JPY 205,000 million and operating income of JPY 17,000 million as compared to the previous forecast of net sales to be JPY 210,000 million and operating income of JPY 12,000 million. Reasons for the revision of financial forecasts: Regarding the consolidated financial forecasts for the first half of the fiscal year ending March 31, 2027, while demand for Electronics & Innovative Products remains steady, the Company anticipates a temporary positive impact on inventory valuation due to sales price revisions implemented in Polymer Solutions products and others to address the rapid rise in raw material and fuel prices caused by the situation in the Middle East, demand for Life Innovation products is expected to fall below initial projections. As a result, net sales are expected to be lower than the previously announced forecast, while operating profit and ordinary profit are expected to exceed the previously announced forecast. In addition, profit attributable to owners of parent is expected to remain unchanged from the previously announced forecast, as the Company anticipates recording an extraordinary loss, such as a loss on liquidation of business, for Denka Performance Elastomer LLC, a U.S.-based subsidiary that has elected not to restart production at its facilities for an indefinite period.

Denka Company Limited, Board Meeting, Jul 13, 2026. Agenda: To continue the share-based remuneration system.

Denka Company Limited, Board Meeting, Aug 07, 2026. Agenda: To entrust additional funds to the Trust for the additional acquisition of Company Shares by the trustee of the Trust.

Denka Company Limited, ¥ 50.0, Cash Dividend, Sep-29-2026

Denka Company Limited proposed dividend for the Fiscal Year Ended March 31, 2026 and Provided Dividend Guidance for Second Quarter- End and Fiscal Year Ending March 31, 2027. For the Fiscal Year Ended March 31, 2026, the company proposed dividend of JPY 50.00 per share compared to JPY 50.00 per share a year ago. Scheduled date of annual general meeting of shareholders: June 19, 2026, Scheduled date to commence dividend payments: June 22, 2026. For the second quarter- end, the company expects dividend of JPY 50.00 per share compared to JPY 50.00 per share a year ago. For the Fiscal Year Ending March 31, 2027, the company expects dividend of JPY 50.00 per share compared to JPY 50.00 per share a year ago.

Denka Company Limited provided consolidated earnings guidance for first half and fiscal year ending March 31, 2027. For the first half, the company expects net sales of JPY 210,000 million. Operating income of JPY 12,000 million. profit attributable to owners of parent of JPY 0, Basic earnings per share of JPY 0.00 For the Full fiscal year, the company expects net sales of JPY 450,000 million. Operating income of JPY 30,000 million. profit attributable to owners of parent of JPY 16,000 million. Basic earnings per share of JPY 185.67.

Denka Company Limited reported earnings results for the full year ended March 31, 2026. For the full year, the company reported sales was JPY 384,247 million compared to JPY 400,251 million a year ago. Net income was JPY 15,695 million compared to net loss of JPY 12,300 million a year ago. Basic earnings per share from continuing operations was JPY 182.1 compared to basic loss per share from continuing operations of JPY 142.73 a year ago.

Denka Company Limited, Annual General Meeting, Jun 19, 2026.

Denka Company Limited announced that they will report Q1, 2027 results on Aug 07, 2026

Denka Company Limited, Q1 2027 Earnings Call, Aug 07, 2026

Denka Company Limited announced that they will report Q4, 2026 results on May 13, 2026

Denka Company Limited, Q4 2026 Earnings Call, May 13, 2026

Denka Company Limited has filed a Shelf Registration. Security Name: Bonds due April 9, 2028 Principal Amount: ¥80 billion

Denka Company Limited (TSE:4061) proposed to acquire 77.65% stake in KAINOS Laboratories, Inc. (TSE:4556) from a group of shareholders for ¥7.9 billion on February 6, 2026. A cash consideration of ¥7.89 billion valued at ¥2285 per share will be paid by Denka Company Limited. As part of consideration, ¥7.89 billion is paid towards common equity of KAINOS Laboratories, Inc. Denka Company Limited intends to launch a Squeeze-Out Procedures, if it acquires the minimum tender shares (1,990,000 shares) and fails to acquire all of the KAINOS Laboratories, Inc's Shares (excluding the Shares Agreed Not to Be Tendered and treasury shares). The transaction is subject to minimum tender. The expected completion of the transaction is March 25, 2026. Sumitomo Mitsui Banking Corporation acted as financial advisor for Denka Company Limited. AGS Consulting Co., Ltd. acted as financial advisor for KAINOS Laboratories, Inc. Nagashima Ohno & Tsunematsu acted as legal advisor for KAINOS Laboratories, Inc. TMI Associates acted as legal advisor for KAINOS Laboratories, Inc. Mizuho Securities Co., Ltd. acted as financial advisor for KAINOS Laboratories, Inc. Denka Company Limited (TSE:4061) completed the acquisition of 77.65% stake in KAINOS Laboratories, Inc. (TSE:4556) from a group of shareholders on March 25, 2026. Upon closing of the offer period, 3,223,919 shares were tendered. Since it is more than the minimum number of shares to be purchased (1,990,000 shares), Denka Company Limited will purchase all of the Tendered Share Certificates and intends to implement a series of procedures for the purpose of making the Tender Offeror the sole shareholder of KAINOS Laboratories, Inc. As of today, the KAINOS Laboratories, Inc's Shares are listed on the Standard Market of the Tokyo Stock Exchange. If the procedures are implemented, the KAINOS Laboratories, Inc's Shares will be delisted pursuant to the prescribed procedures, in accordance with the criteria for delisting of Tokyo Stock Exchange. KAINOS Laboratories, Inc's Shares, after being delisted, will no longer be traded on the Standard Market of the Tokyo Stock Exchange.

Denka Company Limited (TSE:4061) enter into a share transfer agreement to acquire an additional 15% stake in Toyo Styrene Co. Ltd from Daicel Corporation (TSE:4202) on March 9, 2026. Upon completion, Denka Company Limited will own 65% stake in Toyo Styrene Co. Ltd. As a result of this transaction, Toyo Styrene is expected to become a consolidated subsidiary of the Company that qualifies as a specified subsidiary. Daicel will cease to be a co-investor in Toyo Styrene, and Toyo Styrene’s Hirohata Plant will be shut down. For a certain period, however, Toyo Styrene will continue to outsource production to Daicel and maintain product sales. For the period ending March 31, 2025, Toyo Styrene Co. Ltd reported total revenue of ¥48.39 billion, EBIT of ¥1.22 billion and net income of ¥788 million. As of March 31, 2025, Toyo Styrene Co. Ltd reported total assets of ¥27.69 billion and total common equity of ¥11.73 billion. The completion of this share transfer is subject to the completion of the necessary approvals, permissions, or clearances from the relevant authorities in accordance with the Anti-Monopoly Act and other applicable laws and regulations. The expected completion of the transaction is March 31, 2026.

Denka Company Limited, Board Meeting, Mar 09, 2026. Agenda: To consider Change in Equity-Method Affiliate (Becoming a Consolidated Subsidiary).

Denka Company Limited, Board Meeting, Feb 27, 2026. Agenda: To review of the styrene-related businesses of its Polymer Solutions Division, for a possible spin-off targeting April 2027.

Denka Company Limited announced that its Board of Directors passed a resolution on changes in Executive Officers, changes in their work responsibilities at a meeting held on February 6, 2026. Details are as follows: Formation of Executive Officers (Effective April 1, 2026): Masanobu Kosaka has been appointed as Managing Executive Officer and Chief Technical Officer (CTO), where he will oversee Production Engineering, New Business Development Technology Planning Dept., Sustainability Promotion Dept., and Digital Strategy & Innovation Dept.; he currently serves as Managing Executive Officer and Chief Technical Officer (CTO), responsible for Production & Process Technology Dept., Digital Strategy & Innovation Dept., and Engineering Dept. Michio Kawamura has been promoted to Managing Executive Officer and will be in charge of the Omi Plant; he currently serves as Executive Officer overseeing the Environment and Safety Dept., Quality Assurance Dept., and Sustainability Promotion Dept.; Takeshi Hagiwara has been appointed as Executive Officer of the Omuta Plant; he currently serves as Executive Officer of the Omi Plant; Tetsuo Noguchi has been appointed as Executive Officer of the Gosen Site; he currently serves as Executive Officer of the Shibukawa Plant; Koji Nishimura has been appointed as Executive Officer in charge of Production Engineering; he currently serves as Executive Officer of the Omuta Plant; Masahide Yamada has been appointed as Executive Officer in charge of New Business Development; he currently serves as Executive Officer and Chief Scientific Officer (CSO), overseeing New Business Development at the Innovation Center. Jun Nakamoto has been newly appointed as an Executive Officer and President of Denka Performance Elastomer LLC. He joined the company on April 1, 1999, and has held several key positions over his career. On August 1, 2022, he became General Manager of the Organic Materials Department 2 at Omi Plant. On April 1, 2024, he was appointed General Manager of Production Department 4 at Omuta Plant, and on October 1, 2025, he became Assistant to the Chief Technical Officer. Jun Nakamoto has been newly appointed as an Executive Officer and President of Denka Performance Elastomer LLC. He joined the company on April 1, 1999.On August 1, 2022, he became General Manager of the Organic Materials Department 2 at Omi Plant. On April 1, 2024, he was appointed General Manager of Production Department 4 at Omuta Plant, and on October 1, 2025, he became Assistant to the Chief Technical Officer. Osamu Kunitomo was appointed as Executive Officer and General Manager of the R&D Management Department, New Business Development at the Shibukawa Plant on April 1, 1999. His career history includes joining the company on January 1, 2022, serving as General Manager of the Production Department 4 at the Omuta Plant, and later, on April 1, 2024, taking on the role of General Manager of the R&D Management Department, New Business Development. Yukio Sasagawa, currently serving as Managing Executive Officer at the Gosen Site, will retire from his position as Managing Executive Officer. Muneatsu Miida, who is currently an Executive Officer, will also retire from his position as Executive Officer.

Denka Company Limited revised consolidated earning guidance for the fiscal year ending March 31, 2026. For the year, the company expects net sales of JPY 390,000 million; operating income of JPY 25,000 million; net attributable to owners of parent of JPY 15,000 million and basic earnings per share of 174.06 against previous guidance of net sales of JPY 400,000 million; operating income of JPY 25,000 million; net attributable to owners of parent of JPY 15,000 million and basic earnings per share of 174.06.Reasons for revising: The forecasts In the full-year consolidated financial results forecast, the net sales have been revised from the previous forecast announced on November 10, 2025, taking into account recent performance trends. As for operating income forecast, the total amount on a consolidated basis will remain unchanged from the previous forecast announced on May 13, 2025, while the breakdown by segment has been revised.

Denka Company Limited (TSE:4061) proposed to acquire 77.65% stake in KAINOS Laboratories, Inc. (TSE:4556) from a group of shareholders for ¥7.9 billion on February 6, 2026. A cash consideration of ¥7.89 billion valued at ¥2285 per share will be paid by Denka Company Limited. As part of consideration, ¥7.89 billion is paid towards common equity of KAINOS Laboratories, Inc. The transaction is subject to minimum tender. The expected completion of the transaction is March 25, 2026. Sumitomo Mitsui Banking Corporation acted as financial advisor for Denka Company Limited. AGS Consulting Co., Ltd. acted as financial advisor for KAINOS Laboratories, Inc. Nagashima Ohno & Tsunematsu acted as legal advisor for KAINOS Laboratories, Inc. TMI Associates acted as legal advisor for KAINOS Laboratories, Inc. Mizuho Securities Co., Ltd. acted as financial advisor for KAINOS Laboratories, Inc.

Denka Company Limited reported earnings results for the nine months ended December 31, 2025. For the nine months, the company reported sales was JPY 290,774 million compared to JPY 301,598 million a year ago. Net income was JPY 5,535 million compared to JPY 2,577 million a year ago. Basic earnings per share from continuing operations was JPY 64.23 compared to JPY 29.92 a year ago.

Denka Company Limited expected to report Fiscal Year 2026 results on May 13, 2026. This event was calculated by S&P Global (Created on April 22, 2026).

Management Presentation

Denka Company Limited, Q3 2026 Earnings Call, Feb 06, 2026

Denka Company Limited announced that they will report Q3, 2026 results on Feb 06, 2026

Denka Company Limited revised consolidated earnings guidance for the fiscal year ending March 31, 2026. For the year, the company now expects net sales of JPY 400,000 million. Operating income of JPY 25,000 million. Net income attributable to owners of parent of JPY 15,000 million. Basic earnings per share of JPY 174.06 against previous guidance of net sales of JPY 410,000 million. Operating income of JPY 25,000 million. Net income attributable to owners of parent of JPY 15,000 million. Basic earnings per share of JPY 174.06.

Denka Company Limited, ¥ 50.0, Cash Dividend, Mar-30-2026

Denka Company Limited expected to report Q3 2026 results on February 6, 2026. This event was calculated by S&P Global (Created on November 10, 2025).

NAiEEL Technology announced that it has received round of funding on October 17, 2025. The transaction include the participation from new investor Denka Company Limited. The company issued convertible preferred stock in the transaction.

Denka Company Limited, Q2 2026 Earnings Call, Nov 10, 2025